Apatinib induces endoplasmic reticulum stress-mediated apoptosis and autophagy and potentiates cell sensitivity to paclitaxel via the IRE-1α–AKT–mTOR pathway in esophageal squamous cell carcinoma

• Published in: Cell & bioscience 2021-07, Vol.11 (1), p.1-124, Article 124
• Main Authors: Wang, Yu-Ming, Xu, Xin, Tang, Jian, Sun, Zhi-Yong, Fu, Yu-Jie, Zhao, Xiao-Jing, Ma, Xiu-Mei, Ye, Qing
• Format: Article
• Language: English
• Subjects: AKT protein; Antibodies; Antitumor activity; Apatinib; Apoptosis; Autophagy; Cancer therapies; Cell cycle; Cell proliferation; Chemotherapy; Chloroquine; Endoplasmic reticulum; Enzyme inhibitors; ER stress; Esophageal cancer; Esophageal squamous cell carcinoma; Esophagus; Experiments; Gastric cancer; Homeostasis; Immunohistochemistry; Kinases; Laboratory animals; Medical innovations; Medical research; Metastases; Microscopy; Molecular modelling; Paclitaxel; Phagocytosis; Protein-tyrosine kinase; Proteins; Signal transduction; Squamous cell carcinoma; TOR protein; Tumors; Vascular endothelial growth factor; Vascular endothelial growth factor receptors; Xenografts
• ISSN: 2045-3701; 2045-3701
• DOI: 10.1186/s13578-021-00640-2

Background Apatinib, a novel vascular endothelial growth factor receptor-2 (VEGFR-2) tyrosine kinase inhibitor, has been approved for the treatment of metastatic gastric cancer and other tumors. Apatinib exerts antiproliferative and proapoptotic effects in different kinds of cancer cells. However, the molecular mechanisms by which apatinib effective against esophageal squamous cell carcinoma (ESCC) have only been partially researched and whether it has a sensitizing effect on paclitaxel remains unclear. Materials and methods The effects of apatinib or paclitaxel on endoplasmic reticulum (ER) stress, autophagy, apoptosis and proliferation of ESCC cell lines were evaluated. Western blot and immunohistochemistry analyses were performed to detect the expression of related genes. The weight and volume of xenograft tumors in mice were measured. Results In the current study, we elucidated the antiproliferative and ER-stress-mediated autophagy-inducing effects of apatinib on ECA-109 and KYSE-150 esophageal squamous cancer cells and identified the underlying mechanisms of its action. We demonstrated that apatinib not only inhibited the proliferation and induced the apoptosis of ESCC cells, but also activated ER stress and triggered protective autophagy. Moreover, inhibiting autophagy by chloroquine (CQ) enhanced the apatinib-induced apoptosis of ESCC cells through the IRE-1α–AKT–mTOR pathway. In addition, we showed, for the first time, the paclitaxel combined with apatinib and CQ exhibited the best antitumor effect on ESCC both in vivo and in vitro via the IRE-1α–AKT–mTOR pathway. Conclusions Our data showed that apatinib induced ER stress, autophagy and apoptosis in ESCC. Inhibiting autophagy by CQ enhanced apatinib-induced apoptosis. The combination of apatinib and CQ sensitized ESCC cells to paclitaxel to induce apoptosis through the IRE-1α–AKT–mTOR signaling pathway, thus providing the basis for its use in innovative anticancer therapeutic strategies. Graphic abstract